pitfalls – Pharma GMP

Typical Pitfalls in Equipment Changeover and How to Avoid Them

digi — Wed, 26 Nov 2025 02:00:04 +0000

Typical Pitfalls in Equipment Changeover and How to Avoid Them Step-by-Step Guide to Avoiding Typical Pitfalls in Equipment Changeover Procedure GMP In pharmaceutical manufacturing, an effective and compliant equipment changeover procedure GMP is critical to maintaining product quality, batch integrity, and regulatory compliance. Ineffective changeover practices can lead to common issues such as changeover errors,...

Common Pitfalls in Internal Audit Programs and How to Avoid Them

digi — Tue, 25 Nov 2025 20:54:04 +0000

Common Pitfalls in Internal Audit Programs and How to Avoid Them Preventing Internal Audit Pitfalls in Pharmaceutical Manufacturing: A Step-by-Step Guide Internal audits form a cornerstone of pharmaceutical Good Manufacturing Practice (GMP) compliance programs, serving as essential tools to verify adherence to regulatory requirements and internal quality standards. However, internal audit pitfalls pharma can severely...

Case Studies: Method Transfer Pitfalls and How to Avoid Them

digi — Tue, 25 Nov 2025 13:33:04 +0000

Case Studies: Method Transfer Pitfalls and How to Avoid Them Analytical Method Transfer Between R&D and QC: Critical Pitfalls and Best Practices Successful pharmaceutical manufacturing and quality control depend heavily on the seamless analytical method transfer between R&D and QC laboratories. Such transfers must consistently ensure that methods developed in Research and Development are executed...

Common OOS Investigation Pitfalls and FDA Warning Letter Examples

digi — Tue, 25 Nov 2025 11:12:04 +0000

Common OOS Investigation Pitfalls and FDA Warning Letter Examples Step-by-Step Guide to Avoiding Common Pitfalls in OOS Investigations in QC Laboratory Out-of-specification (OOS) results present a critical challenge for pharmaceutical quality control (QC) laboratories, requiring systematic and compliant investigations rooted in Good Manufacturing Practice (GMP). Regulatory agencies such as the US Food and Drug Administration...

Common Pitfalls in Dirty and Clean Hold Time Studies

digi — Tue, 25 Nov 2025 01:00:42 +0000

Common Pitfalls in Dirty and Clean Hold Time Studies Understanding and Avoiding Common Pitfalls in Dirty and Clean Hold Time Studies Dirty hold time and clean hold time studies are critical components of pharmaceutical Good Manufacturing Practice (GMP) compliance, designed to ensure product quality and patient safety. These studies establish maximum allowable durations between equipment...

Typical Pitfalls in Equipment Changeover and How to Avoid Them

digi — Mon, 24 Nov 2025 21:18:42 +0000

Typical Pitfalls in Equipment Changeover and How to Avoid Them Typical Pitfalls in Equipment Changeover and How to Avoid Them: A Step-by-Step GMP Tutorial The pharmaceutical manufacturing environment demands stringent controls to ensure product quality, patient safety, and regulatory compliance. One critical process that often presents challenges is the equipment changeover procedure. Failure to perform...